SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-123307
Filing Date
2020-11-10
Accepted
2020-11-10 06:34:24
Documents
15
Period of Report
2020-11-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035421d1_8k.htm   iXBRL 8-K 30664
2 EXHIBIT 1.1 tm2035421d1_ex1-1.htm EX-1.1 195429
3 EXHIBIT 5.1 tm2035421d1_ex5-1.htm EX-5.1 8202
4 GRAPHIC tm2035421d1_ex5-1img001.jpg GRAPHIC 5466
  Complete submission text file 0001104659-20-123307.txt   464996

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nvax-20201110.xsd EX-101.SCH 3183
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20201110_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20201110_pre.xml EX-101.PRE 22708
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2035421d1_8k_htm.xml XML 3483
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 201299551
SIC: 2836 Biological Products, (No Diagnostic Substances)